Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant

This study has been completed.
Information provided by:
University Hospital, Geneva Identifier:
First received: April 25, 2007
Last updated: NA
Last verified: April 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given